Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions

Breast

Volumn 15, Issue 6, 2006, Pages 705-712

  Pavlakis, K ^a   Zoubouli, Chr ^a   Liakakos, Th ^a   Messini, I ^b   Keramopoullos, A ^b   Athanassiadou, S ^a   Kafousi, M ^c   Stathopoulos, E N ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b IASO   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

p63; Sclerosing breast lesions; SMA

Indexed keywords

PROTEIN ANTIBODY; PROTEIN P63; SMOOTH MUSCLE ACTIN;

ANTIBODY LABELING; ARTICLE; BREAST LESION; BREAST PAPILLOMA; CARCINOMA IN SITU; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MYOEPITHELIUM CELL; MYOFIBROBLAST; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE FIBER;

EID: 33751172556     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.11.005     Document Type: Article

References (23)

1. Batistatou A., Stefanou D., Arkoumani E., and Agnantis N.J. The usefulness of p63 as a marker of breast myoepithelial cells. In Vivo 17 (2003) 573-576
2. Chauhan H., Abraham A., Phillips J.R., Pringle J.H., Walker R.A., and Jones J.L. There is more than one kind of myofibroblasts: analysis of CD34 expression in benign, in situ and invasive breast lesions. J Clin Pathol 56 (2003) 271-276
3. Goldfarb R.H., and Liotta L.A. Proteolytic enzymes in cancer invasion and metastasis. Semin Thromb Hemost 12 (1986) 294-307
4. King T.A., Scharfenberg J.C., Smetherman D.H., Farkas E.A., Bolton J.S., and Fuhrman G.M. A better understanding of the term radial scar. Am J Surg 180 (2000) 428-433
5. Lerwill F.M. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 28 (2004) 1076-1091
6. Zhang R.R., Man Y.G., Vang R., Saenger J.S., Barner R., Wheeler D.T., et al. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res 5 (2003) 151-156
7. Moritani S., Kushima R., Sugihara H., Bamba M., Kobayashi T.K., and Hattori T. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol 15 (2002) 397-405
8. Stefanou D., Batistatou A., Nonni A., Arkoumani E., and Agnantis N.J. P63 expression in benign and malignant breast lesions. Histol Histopathol 19 (2004) 465-471
9. Wang X., Mori I., Tang W., Nakamura M., Nakamura Y., Sato M., et al. p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer 9 (2002) 216-219
10. Zhou M., Shah R., Shen R., and Rubin M.A. Basal cell cocktail (34betaE12+p63) improves the detection of prostate basal cells. Am J Surg Pathol 27 (2003) 365-371
11. Koker M.M., and Kleer C.G. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 28 (2004) 1506-1512
12. El-Zammar O.A., and Haidar A. Immunoreactivity of ductal cells with putative myoepithelial markers: a potential pitfall in breast carcinoma. Ann Diagn Pathol 7 (2003) 335
13. Nayar R., Breland C., Bedrossian U., et al. Immunoreactivity of ductal cells with putative myoepithelial markers: a potential pitfall in breast carcinoma. Ann Diagn Pathol 3 (1999) 165-173
14. Lee A.H., Denley H.E., Pinder S.E., Ellis I.O., Vujovic P., Macmillan R.D., et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesions of uncertain malignant potential (B3). Histopathology 42 (2003) 331-336
15. Prasad M.L., Hyjek E., Giri D.D., Ying L., O'Leary J.J., and Hoda S.A. Double immunolabeling with cytokeratins and smooth-muscle-actin in confirming early invasive carcinoma of breast. Am J Surg Pathol 23 (1999) 176-181
16. Sloane J.P., and Mayers M.M. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 23 (1993) 225-231
17. Wang N.P., Wan B.C., Skelly M., et al. Antibodies to novel myoepithelium associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem 5 (1975) 141-151
18. Yaziji H., Gown A.M., and Sneige N. Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol 7 (2000) 100-109
19. Wang F., Weaver V.M., Petersen O.W., Larabell C.A., Dedhar S., Briand P., et al. Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95 (1998) 14821-14826
20. Boecker W., and Buerger H. Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif 36 Suppl 1 (2003) 73-84
21. Bankfalvi A., Ludwig A., De-Hesselle B., Buerger H., Buchwalow I.B., and Boecker W. Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases. Mod Pathol 17 (2004) 1051-1061
22. Shah R.B., Kunju L.P., Shen R., LeBlanc M., Zhou M., and Rubin M.A. Usefulness of basal cell cocktail (34betaE12+p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol 122 (2004) 517-523
23. Werling R.W., Hwang H., Yaziji H., and Gown A.M. Immunohistochemical distinction of invasive from non-invasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol 27 (2003) 82-90